The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

Financial Stability: Eli Lilly's balance sheet is more robust, with debt making up only 4% of equity, considerably less than ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

A significant trading signal occurred for Eli Lilly stock, as it demonstrated a power inflow at $734.98, after which LLY rose ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Eli Lilly has morphed from a reliable pharma giant into a biotech powerhouse riding blockbuster success. Mounjaro and ...

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...

DelveInsight's "FILSPARI Market Size, Forecast, and Market Insight Report" highlights the details around FILSPARI, the first and only ...

The stock's rise snapped a five-day losing streak.

Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, USA, with products marketed in 120 countries. Eli Lilly Austria, Switzerland, Germany is the company’s third ...

Shares of Eli Lilly & Co. LLY shed 1.34% to $715.20 Thursday, on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average DJIA remaining mostly ...